IGF2BP1 and rectal cancer: Next, the microarray expression data of a total of 107 CRC patients (91 colon cancer and 16 rectal cancer patients) ≥50 y/o without receiving radiotherapy were retrieved from a ROC plotter web tool (http://www.rocplot.org/ (accessed on 1 June 2021) to examine the association of IGF2BP1 expression and chemotherapy resistance.